For EB@MPCM+Laser group, in situ release of PD‐L1 trap at tumor site enhanced this effect (35.2% of DC maturation), and the proportion of CD8+T cells reached the highest level (60.5%) (Figure 6C; Figure S11B, Supporting Information). Here, CD8A is linked to neoplasm.